Company / Operating Cash Flow per Share
Teladoc Health, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$1.70
FY2025
5-year range
$1.18 / $2.15
FY2021-FY2025
Trend
-3.7%
vs FY2024
Sector context
#94 of 155
Health Care
What the data says
At $1.70, Teladoc Health, Inc.'s operating cash flow per share ranks #94 of 155 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.35 in FY2016 to $2.15 in FY2023.
Based on SEC 10-K filings.
1.70 in FY2025 with a 3-year CAGR of +12.9%.
Declined from $2.15 to $1.70 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +12.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#94 of 155 in Health CareTop 61% of 155This company $1.70 Sector average $6.77
▼
-74.9% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 3.7% year-over-year.
- Ranks #94 out of 155 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.70 | -3.7% |
| FY2024 | $1.76 | -18.0% |
| FY2023 | $2.15 | +82.2% |
| FY2022 | $1.18 | -4.6% |
| FY2021 | $1.24 | +309.1% |
| FY2020 | -$0.59 | -242.2% |
| FY2019 | $0.42 | +626.4% |
| FY2018 | -$0.08 | +89.4% |
| FY2017 | -$0.75 | +44.6% |
| FY2016 | -$1.35 | +94.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026